Stem cell, tumor and bone marrow microenvironment cross-talk in vivo
体内干细胞、肿瘤和骨髓微环境的串扰
基本信息
- 批准号:7430502
- 负责人:
- 金额:$ 230.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcylationAddressAdhesivesAffectAffinityAnatomyAnimal ModelAnimalsAntibodiesAntigen-Presenting CellsAntigensApoptosisApoptoticArchitectureAreaArgonArtsAscaridilAspirate substanceAvidinAwardB-LymphocytesBehaviorBenignBibliographyBindingBiological AssayBiological AvailabilityBiologyBiotechnologyBiotinBloodBlood CellsBlood Component RemovalBlood VesselsBlood specimenBone MarrowBone Marrow NeoplasmsBone Marrow Stem CellBone Marrow TransplantationBone marrow biopsyCD19 geneCD3 AntigensCD34 geneCSF3 geneCXCR4 ReceptorsCXCR4 geneCalcium-Sensing ReceptorsCalvariaCancer BiologyCancerousCell AdhesionCell Adhesion MoleculesCell CommunicationCell LineCell SurvivalCell TherapyCell divisionCell membraneCell physiologyCell surfaceCellsCharacteristicsChargeChemistryChemokine, OtherChicagoClassClinicalClinical ResearchCoculture TechniquesCollaborationsCommunicationCommunitiesComplexConfocal MicroscopyCountCulture MediaDNADana-Farber Cancer InstituteDataDeath RateDendritic CellsDependenceDepthDetectionDevelopmentDextransDimensionsDisciplineDiseaseDockingDoseDrug Delivery SystemsDrug MonitoringDyesE-SelectinElementsEncapsulatedEnd PointEndothelial CellsEngineeringEngraftmentEnvironmentErythroid CellsEthylene GlycolsEventExhibitsExperimental Animal ModelExperimental ModelsExposure toExtracellular MatrixExtracellular Matrix ProteinsFilmFlow CytometryFluorescenceFluorescent Antibody TechniqueFosteringFutureGaliumGasesGeneral HospitalsGoalsGreen Fluorescent ProteinsGrowthGrowth FactorHalf-LifeHarvestHematologic NeoplasmsHematologyHematopoiesisHematopoieticHematopoietic stem cellsHeterogeneityHistologyHome environmentHomeostasisHomingHomologous GeneHourHumanHybridsITGAM geneITGAX geneImageImage AnalysisImaging TechniquesImmersion Investigative TechniqueImmuneImmunocompromised HostImmunofluorescence ImmunologicImmunohistochemistryImmunologyImmunomagnetic SeparationIn VitroIncubatedIndividualInflammatoryInjection of therapeutic agentInstitutionIntegrin alpha4beta1Integrin alpha5beta1Interphase CellInvasiveInvestigationJournalsKnowledgeKryptonLabelLaboratoriesLaboratory ResearchLasersLateralLeadLearningLegal patentLettersLeukemic CellLeukemic Hematopoietic Stem CellLifeLigandsLipidsLiposomesLiteratureLocalizedLocationLongitudinal StudiesLymphoidMagnetic Resonance ImagingMagnetismMaintenanceMalignant - descriptorMalignant NeoplasmsManualsManufacturer NameMarrowMassachusettsMeasuresMediatingMediator of activation proteinMedicalMedicineMembraneMembrane FluidityMetastatic Neoplasm to the Bone MarrowMethodsMicroscopeMicroscopyMicrospheresMinorityModelingMolecularMolecular ProbesMolecular ProfilingMolecular TargetMolecular and Cellular BiologyMusMutationMyelogenousN-CadherinNanotechnologyNatural regenerationNatureNeoplasm MetastasisNeoplastic Endothelial CellNeuronsNormal CellNumbersOccupationsOncologyOrganic solvent productOsteoblastsOutcomeP-SelectinPathologicPathologyPatientsPatternPerivascular NeoplasmPharmaceutical PreparationsPhosphorylcholinePhotonsPhysical ChemistryPhysicsPhysiologicalPlayPolyethylene GlycolsPolymer ChemistryPolymerase Chain ReactionPopulationPositioning AttributePre-B Acute Lymphoblastic LeukemiaProbabilityProcessPropertyProto-Oncogene Protein c-kitProtocols documentationRNARadiology SpecialtyRangeRateReactionReceptor CellRecording of previous eventsRegulationResearchResearch DesignResearch Ethics CommitteesResearch PersonnelResistanceResolutionResourcesReticular CellReverse Transcriptase Polymerase Chain ReactionRiskRoleRunningSCID MiceSalineSamplingSapphireScanningScienceScientistScreening procedureSensitivity and SpecificitySerumShapesSignal TransductionSignal Transduction PathwaySiteSmall Interfering RNASolutionsSorting - Cell MovementSpeedSpleenStagingStandards of Weights and MeasuresStem Cell DevelopmentStem cell transplantSterilityStimulusStressStromal Cell-Derived Factor 1Stromal CellsStudentsSurfaceSystemT-LymphocyteTailTechniquesTechnologyTestingTherapeuticThinkingTimeTissue BanksTissuesTitaniumTitrationsTrainingTranslational ResearchTransplantationTreatment ProtocolsTumor AngiogenesisTumor BiologyTumor Cell InvasionTumor Stem CellsUniversitiesVascular Cell Adhesion Molecule-1Vascular Endothelial CellVascular Endothelial Growth FactorsVeinsVisible RadiationWaterWeekWorkXenograft ModelXenograft procedureabstractingangiogenesisantibody conjugateaqueousbasebody systembonecancer cellcancer stem cellcancer therapycareercell behaviorcell growthcell motilitycell typecellular imagingchemokinechemokine receptorchemotherapyclinical applicationclinically significantcraniumcyaninecyanine dyecytokinecytotoxicdaydesigndesiredetectordextrandisorder controlethylene glycolexperiencefluorophoreforgingfunctional grouphuman diseaseimprovedin vivoinhibitor/antagonistinnovationinsightinterestintravital fluorescence microscopyintravital microscopyirradiationlensleukemiamacrophagemagnetic cell separationmanmicrocalorimetrymigrationmolecular dynamicsmolecular imagingmouse modelnanoparticleneoplastic cellneovascularizationnew technologynotch proteinnovelnovel strategiesnovel therapeuticsoutcome forecastparticleperipheral bloodpre-clinicalpreventprogenitorprogramsprototypereceptorresearch studyresponseresponse to injuryself-renewalsizeskillssmall moleculestemstem cellssuccesstargeted deliverytherapeutic targettooltraffickingtumortumor eradicationtumor growthtwo-photonuptakezeta potential
项目摘要
A growing body of evidence suggests that the host microenvironment plays an important role in the
regulation of both normal and malignant stem cell self-renewal and differentiation. The specific locations,
cellular components and molecular details of these stem cell niches are, however, little understood. Using in
vivo confocal and multiphoton molecular imaging techniques to study cell interactions in the intact murine bone
marrow (BM), we have defined a novel perivascular tumor and hematopoietic stem/progenitor cell (HSPC)
niche. We have identified the molecules used by leukemic cells to access this niche, however the mechanisms
governing HSC transit to these areas have not yet been defined. Moreover, the role of this niche in
maintaining normal HSCs or coordinating specific HSC cell functions is unknown. Given the importance of
HSC-based transplantation therapies as well as the clinical significance of tumor metastasis to the BM, there is
great therapeutic potential in understanding these cellular interactions. The long-term goals of our research
are, therefore, to define the molecular architecture and functional significance of this tumor and HSC niche
using state-of-the-art in vivo imaging techniques combined with cell and molecular biology approaches.
Specifically, we will 1) examine the mechanisms governing HSC transit and engraftment in these niches, 2)
determine how tumor growth impacts the niche and whether tumor and benign HSCs compete within the niche,
and 3) develop targeted nanoparticles to release encapsulated compounds in precise regions of the vascular
niche. These nanoparticles will serve as a unique tool to elucidate the critical molecules that mediate HSC and
tumor proliferation in the niche and as a prototype for a targeted drug delivery agent. Ultimately, we aim to use
the knowledge from these studies to design specific anti-tumor treatments that spare normal hematopoiesis
and to define factors that improve the efficacy of stem cell-based therapies.
越来越多的证据表明,宿主微环境在
调节正常和恶性干细胞自我更新和分化。特定位置,
然而,这些干细胞壁ni的细胞成分和分子细节尚不清楚。使用
体内共聚焦和多光子分子成像技术,用于研究完整鼠骨中细胞相互作用
骨髓(BM),我们定义了一种新型的周围肿瘤和造血茎/祖细胞(HSPC)
利基。我们已经确定了白血病细胞用于进入这种利基的分子,但是机制
尚未定义管理到这些领域的HSC运输。而且,这个利基在
维持正常的HSC或协调特定的HSC细胞功能是未知的。考虑到重要性
基于HSC的移植疗法以及肿瘤转移对BM的临床意义,有
理解这些细胞相互作用的巨大治疗潜力。我们研究的长期目标
因此,是为了定义该肿瘤和HSC生态位的分子结构和功能意义
使用最新的体内成像技术结合细胞和分子生物学方法。
具体而言,我们将1)检查这些壁ches中HSC过境和植入的机制,2)
确定肿瘤生长如何影响小众以及肿瘤和良性HSC是否在小众内竞争,
3)开发靶向纳米颗粒以释放血管精确区域的封装化合物
利基。这些纳米颗粒将作为阐明介导HSC和HSC的关键分子的独特工具
利基市场中的肿瘤增殖,作为靶向药物递送剂的原型。最终,我们的目标是使用
这些研究的知识到设计特定的抗肿瘤治疗,以备受正常的造血作用
并定义提高基于干细胞疗法的功效的因素。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dorothy A Sipkins其他文献
Dorothy A Sipkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dorothy A Sipkins', 18)}}的其他基金
Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
识别和利用导致骨到脑膜乳腺癌转移的肿瘤与宿主相互作用的治疗脆弱性
- 批准号:
10826488 - 财政年份:2023
- 资助金额:
$ 230.25万 - 项目类别:
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
- 批准号:
10455633 - 财政年份:2021
- 资助金额:
$ 230.25万 - 项目类别:
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
- 批准号:
10289183 - 财政年份:2021
- 资助金额:
$ 230.25万 - 项目类别:
Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
定义和靶向中枢神经系统软脑膜转移的新途径
- 批准号:
10322127 - 财政年份:2020
- 资助金额:
$ 230.25万 - 项目类别:
Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
定义和针对中枢神经系统软脑膜转移的新途径
- 批准号:
10553654 - 财政年份:2020
- 资助金额:
$ 230.25万 - 项目类别:
Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
定义和靶向中枢神经系统软脑膜转移的新途径
- 批准号:
9888134 - 财政年份:2020
- 资助金额:
$ 230.25万 - 项目类别:
Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
定义和针对中枢神经系统软脑膜转移的新途径
- 批准号:
10079480 - 财政年份:2020
- 资助金额:
$ 230.25万 - 项目类别:
Defining the Rules of Breast Cancer Cell Traffic Through Bone
定义乳腺癌细胞通过骨运输的规则
- 批准号:
10368923 - 财政年份:2017
- 资助金额:
$ 230.25万 - 项目类别:
Defining the Rules of Breast Cancer Cell Traffic Through Bone
定义乳腺癌细胞通过骨运输的规则
- 批准号:
10066311 - 财政年份:2017
- 资助金额:
$ 230.25万 - 项目类别:
Defining the Rules of Breast Cancer Cell Traffic Through Bone
定义乳腺癌细胞通过骨运输的规则
- 批准号:
9239952 - 财政年份:2017
- 资助金额:
$ 230.25万 - 项目类别:
相似国自然基金
胆固醇代谢调控线粒体去酰化酶Sirt5介导的蛋白翻译后修饰在骨关节炎中的作用与机制研究
- 批准号:82302746
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
仙茅酚苷类成分靶向组蛋白去乙酰化酶HDAC1抑制BMSC衰老防治老年性骨质疏松的机制
- 批准号:82304806
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GFAP-C291棕榈酰化激活星型胶质细胞在阿尔茨海默病中的作用和机制及干预研究
- 批准号:32371309
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALDOA琥珀酰化修饰通过线粒体动力学调控突触可塑性参与癫痫形成的机制研究
- 批准号:82360268
- 批准年份:2023
- 资助金额:32.2 万元
- 项目类别:地区科学基金项目
相似海外基金
Palmitoylation-dependent regulation of the actin cytoskeleton in dendritic spines
树突棘中肌动蛋白细胞骨架的棕榈酰化依赖性调节
- 批准号:
8682536 - 财政年份:2014
- 资助金额:
$ 230.25万 - 项目类别:
Regulation of T cell anergy by palmitoyl acyl transferases
棕榈酰酰基转移酶对 T 细胞无反应性的调节
- 批准号:
7753678 - 财政年份:2009
- 资助金额:
$ 230.25万 - 项目类别:
Regulation of T cell anergy by palmitoyl acyl transferases
棕榈酰酰基转移酶对 T 细胞无反应性的调节
- 批准号:
7571748 - 财政年份:2009
- 资助金额:
$ 230.25万 - 项目类别:
HUMAN GENETIC VARIATION IN FATTY ACID METABOLISM AND SUDDEN CARDIAC ARREST
脂肪酸代谢和心脏骤停的人类遗传变异
- 批准号:
8011714 - 财政年份:2008
- 资助金额:
$ 230.25万 - 项目类别:
HUMAN GENETIC VARIATION IN FATTY ACID METABOLISM AND SUDDEN CARDIAC ARREST
脂肪酸代谢和心脏骤停的人类遗传变异
- 批准号:
7585808 - 财政年份:2008
- 资助金额:
$ 230.25万 - 项目类别: